Ironwood Pharmaceuticals | IRWD - Operating Profit



Ironwood Pharmaceuticals reported $33.22M in Operating Profit for its fiscal quarter ending in December of 2024.


Operating Profit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Agios Pharmaceuticals USD -127056000 20.43M Jun/2025
Almirall EUR 43.02M 8.82M Jun/2025
Alnylam Pharmaceuticals USD -16199000 34.28M Jun/2025
Amarin USD -16755000 35.77M Mar/2025
Ardelyx USD -14400000 22.52M Jun/2025
Astellas Pharma JPY 92.54B 29.02B Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
Charles River Laboratories USD 132.33M 57.66M Jun/2025
Exact Sciences USD -2148000 93.86M Jun/2025
Halozyme Therapeutics USD 202.44M 60.91M Jun/2025
Incyte USD 310.82M 105.66M Jun/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
MacroGenics USD -36760000 20.17M Jun/2025
Moderna USD -907000000 143M Jun/2025
Myriad Genetics USD -29000000 10M Mar/2025
Pacira USD 10.23M 8.24M Jun/2025
PTC Therapeutics USD -34858000 1.01B Jun/2025
Sarepta Therapeutics USD 115.58M 415.96M Jun/2025
Takeda JPY 184.56B 259.5B Jun/2025
Ultragenyx Pharmaceutical USD -193567000 50.63M Jun/2025